← Open Payments lookup

MANISHA WADHWA: Open Payments

NPI 1851376354 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$22,297 in 60 payments from 14 companies in 2025. Trend: 2023 $4,148 · 2024 $39,935 · 2025 $22,297

Speaker / faculty: $13,950Consulting: $6,230Food & beverage: $1,215Travel & lodging: $903
CompanyPaymentsAmount
Alkermes, Inc.23$14,931
ABBVIE INC.8$6,737
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$132
Supernus Pharmaceuticals, Inc.5$81
Neurocrine BioSciences, Inc.3$72
Vanda Pharmaceuticals Inc.3$68
Axsome Therapeutics, Inc.2$57
E.R. Squibb & Sons, L.L.C.3$50
Otsuka America Pharmaceutical, Inc.2$47
Teva Pharmaceuticals USA, Inc.2$46

Products named: LYBALVI, VRAYLAR, CAPLYTA, Qelbree, INGREZZA, Auvelity, FANAPT, COBENFY.

Industry payments across DE — which companies pay providers there.